These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8904522)
1. Assay of human erythrocyte sodium-dependent lithium efflux: the importance of timing of blood sampling. Adebayo GI; Gaffney P; Sinnott M; Feely J Eur J Clin Invest; 1996 Feb; 26(2):131-5. PubMed ID: 8904522 [TBL] [Abstract][Full Text] [Related]
2. Catamenial variations in erythrocyte sodium-lithium countertransport and blood pressure. Adebayo GI; Hemeryck L; Hall M; Gasparro D; Sinnott M; Feely J Clin Sci (Lond); 1997 Jul; 93(1):29-34. PubMed ID: 9279200 [TBL] [Abstract][Full Text] [Related]
3. Correction for the adverse influence of sodium-potassium cotransport on apparent sodium-lithium countertransport activity in human erythrocytes. Hardman TC; Morrish Z; Patel M; Chalkley S; Noble MI J Pharmacol Toxicol Methods; 2002; 47(1):19-24. PubMed ID: 12387935 [TBL] [Abstract][Full Text] [Related]
4. A study of the temporal effect of alcohol on human erythrocyte sodium-lithium countertransport in relation to membrane cholesterol and phospholipids. Adebayo GI; Gaffney P; Feely J Alcohol; 1996; 13(6):597-602. PubMed ID: 8949955 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologies. Hardman TC; Thomas T; Lant AF J Membr Biol; 1998 Jan; 161(2):197-205. PubMed ID: 9435275 [TBL] [Abstract][Full Text] [Related]
7. Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension. Thomas TH; Rutherford PA; West IC; Wilkinson R Eur J Clin Invest; 1995 Apr; 25(4):235-40. PubMed ID: 7601199 [TBL] [Abstract][Full Text] [Related]
8. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension. Rutherford PA; Thomas TH; Laker MF; Wilkinson R Eur J Clin Invest; 1992 Nov; 22(11):719-24. PubMed ID: 1478240 [TBL] [Abstract][Full Text] [Related]
9. Assay of sodium-lithium countertransport rate by direct measurement of erythrocyte lithium concentrations. Siebers RW; Maling TJ Clin Chim Acta; 1987 Oct; 168(3):329-36. PubMed ID: 3677431 [TBL] [Abstract][Full Text] [Related]
10. Erythrocyte Na(+)-H+ exchanger and Na(+)-Li+ countertransport activity in primary aldosteronism. Delva P; Pastori C; Degan M; Montesi G; Bassi A; Lechi A Eur J Clin Invest; 1994 Dec; 24(12):794-8. PubMed ID: 7705372 [TBL] [Abstract][Full Text] [Related]
11. Erythrocyte sodium-lithium countertransport: relationship with plasma renin activity, aldosterone and atrial natriuretic peptide in a population study. Strazzullo P; Cappuccio FP; Miller MA; Buckley MG; Sagnella GA; Trevisan M; Pagano E; MacGregor GA J Hum Hypertens; 1994 Mar; 8(3):199-204. PubMed ID: 8006920 [TBL] [Abstract][Full Text] [Related]
12. Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects. Zerbini G; Ceolotto G; Gaboury C; Mos L; Pessina AC; Canessa M; Semplicini A Hypertension; 1995 May; 25(5):986-93. PubMed ID: 7737738 [TBL] [Abstract][Full Text] [Related]
14. Urinary retinol-binding protein (RBP) excretion and erythrocyte sodium-lithium countertransport (SLC) activity in a cohort of healthy normotensive subjects. Hardman TC; Dubrey SW; Soni S; Clifford R; Chalkley S; Wierzbicki AS J Hum Hypertens; 1999 Dec; 13(12):871-3. PubMed ID: 10618681 [No Abstract] [Full Text] [Related]
15. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients. Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension. Hardman TC; Wierzbicki AS; Croft P; Feher M; Cox A; Lant AF J Hum Hypertens; 1996 Jun; 10(6):429-30. PubMed ID: 8872813 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and erythrocyte sodium-lithium countertransport in essential hypertension. Tournoy KG; Delanghe JR; Duprez DA; De Buyzere ML; Verbeeck RM; Vergauwe DA; Leroux-Roels GG; Clement DL Clin Chim Acta; 1996 Nov; 255(1):39-55. PubMed ID: 8930412 [TBL] [Abstract][Full Text] [Related]
18. Erythrocyte sodium-lithium countertransport activity is inversely correlated to adiponectin, retinol binding protein 4 and body height. Elias E; Wallenius V; Herlitz H; Bergström GM; Olson FJ; Behre CJ Scand J Clin Lab Invest; 2010 Nov; 70(7):487-91. PubMed ID: 20849357 [TBL] [Abstract][Full Text] [Related]
19. Sodium-lithium countertransport in children with nephrotic syndrome. Tulassay T; Dobos M; Luczay A; Stubnya G; Reusz GS; Vásárhelyi B; Sallay P; Szabó A Pediatr Nephrol; 1999 Aug; 13(6):510-3. PubMed ID: 10452280 [TBL] [Abstract][Full Text] [Related]
20. Independence of dimethylamiloride-sensitive Li+ efflux pathways and Na+-Li+ countertransport in human erythrocytes. Zerbini G; Mangili R; Pozza G Biochim Biophys Acta; 1998 Apr; 1371(1):129-33. PubMed ID: 9565666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]